Trial · NCT03386136
Therapeutic Oxygen for Gastrointestinal Atony (TOGA)
NCT03386136, Phase 1, Completed, University of Florida
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Therapeutic Oxygen for Gastrointestinal Atony (TOGA). Trials, record NCT03386136. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03386136
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Therapeutic Oxygen for Gastrointestinal Atony (TOGA)
- NCT number
- NCT03386136
- Status
- Completed
- Phases
- Phase 1
- Enrollment
- 17 participants, actual
- Lead sponsor
- University of Florida
- Conditions
- Ileus, Ogilvie Syndrome, Small Bowel Obstruction
- Interventions
- 100% Oxygen
- First posted
- 2017-12-29
- Last updated
- 2019-12-12
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Changes in Diameter of Colon | 6 - 24 hours | X-ray of kidney, ureter and bladder (KUB) to determine maximal cecal diameter, maximal mid-transverse colon diameter, maximal mid-sigmoid colon diameter. |
| Primary | Changes in Diameter of the Small Bowel | 6 - 24 hours | X-ray of kidney, ureter and bladder (KUB) to determine maximal cecal diameter, maximal mid-transverse colon diameter, maximal mid-sigmoid colon diameter. |
| Secondary | Demonstrates No Resolution of Ileus | 24 - 30 hours after initial TOGA | A second treatment with TOGA will be offered. |
| Secondary | Worsening of Ileus | 24 - 30 hours after initial TOGA | Worsening of ileus after initial treatment but not requiring surgical or endoscopic intervention, will be offered a second treatment of TOGA. |
| Secondary | Need for endoscopic or surgical intervention | 24 - 30 hours after initial TOGA | Worsening of ileus after initial treatment, requiring surgical or endoscopic intervention |
| Secondary | Length of Hospital Stay | up to 100 weeks | Length of stay, measured at the end of hospitalization |
| Secondary | Patient Complaints | Up to 48 hours | Recording of patient perception/tolerance \[daily\] of TOGA. |
| Secondary | Patient Pain Measurement | Up to 48 hours | Patient pain measurement determined subjectively through a visual analogue scale (VAS) scale of 0 (no pain) to 10 (worst pain imaginable) taken before and after TOGA treatment. |
| Secondary | Medication Measurement | 24 hours before through 24 hours after TOGA | Documenting medication requirements for patients exposed to TOGA.(past 24 hours on a scale of 0 (no pain) to 10 (worst pain imaginable) |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 39131150 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03386136
GET https://conductscience.org/api/trials/v1/NCT03386136/registered